Article

Bethany Andrews Rhoten on Body Image Issues Among Patients With Head and Neck Cancer

Author(s):

Bethany Andrews Rhoten

Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses body images among patients and survivors of head and neck cancer.

Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses body image issues among patients and survivors of head and neck cancer.

Related Videos
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
Raising Awareness of Financial Struggles Faced by AYA Cancer Survivors
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care
Image of woman.
Research Shines Light on Disparities Across Breast Cancer Care
Image of woman.
Why Physical Therapy Should Begin at the Time of a Cancer Diagnosis
Image of woman.
Rina-S Generates Antitumor Activity in Heavily Pretreated Ovarian Cancer
Image of man wearing baseball cap backwards.
A Patient Advocate Highlights Kidney Cancer Awareness and Specialized Care
Image of smiling doctor.
Top 3 Takeaways From ASCO GU 2025
Image of Doctor.
Dr. Sheri Prentiss on Steps for Lymphedema Screening in Breast Cancer
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Emphasizing the Importance of Breast Cancer Education and Screenings
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
The Power of Knowledge and Staying Informed in Breast Cancer Care
Related Content
Image of woman holding her neck.
March 31st 2025

Patient With Head and Neck Cancer Dosed in Trial of APR-1051

Alex Biese
A patient with HPV-positive head and neck squamous cell carcinoma was dosed in a phase 1 clinical trial evaluating APR-1051.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population: © Konstantin Yuganov - stock.adobe.com
March 28th 2025

Childhood Cancer Survivors May Experience Sooner Aging-Related Disease

Alex Biese
Researchers have found childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Image of cancer vaccine.
March 25th 2025

New Cancer Vaccine, EVM14, Cleared for Investigational Drug Application

Spencer Feldman
EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach this stage.
Orca-T improved survival free of moderate-to-severe cGVHD across leukemia subtypes: © nobeastsofierce - stock.adobe.com.
March 18th 2025

Orca-T Doubles Graft-Versus-Host Disease-Free Survival in Leukemia

Spencer Feldman
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease across leukemia subtypes.